Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net earnings (loss)	$ 378	$ (10,548)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Loss (earnings) from discontinued operations, net of income taxes	(1,931)	468
Depreciation and amortization	992	1,313
Change in fair value of common stock warrant liability	3,400	(8,450)
Gain on sale of investment securities, available for sale		(380)
Amortization of share-based compensation	965	1,503
Nonmarketable equity securities impairment		581
Inventory impairment	432
Goodwill impairment	400
Proceeds from sale of loans held for sale, net		27,073
Gain on sale of loans held for sale, net		(5,026)
Other	29	(211)
Changes in assets and liabilities:
Restricted cash	2,784
Trade accounts receivable, net	(1,199)	(530)
Inventory	(1,257)	(172)
Other current assets	(902)	512
Other noncurrent assets	(276)	39
Trade payables	1,610	1,348
Other current liabilities	516	317
Other noncurrent liabilities	254	176
Net cash used in operating activities of discontinued operations	(898)	(1,256)
Net cash provided by (used in) operating activities	(1,503)	23,657
Cash flows from investing activities:
Proceeds from sale of investment securities, available for sale		3,228
Advances, net under revolving credit facilities in loans receivable, net		(2,272)
Principal collections on loans receivable, net	153	483
Purchases of property and equipment	(219)	(252)
Net cash provided by investing activities of discontinued operations	114	2,633
Net cash provided by investing activities	48	3,820
Cash flows from financing activities:
Advances (repayments), net on line of credit	680	(500)
Principal payments on long-term debt	(2,625)	(2,633)
Common stock acquired	(99)	(41)
Payment of contingent consideration		(4,000)
Proceeds from exercise of common stock options	286	62
Common stock warrant consideration	48	60
Net cash used in financing activities	(1,710)	(7,052)
Increase (decrease) in cash and cash equivalents	(3,165)	20,425
Cash and cash equivalents, beginning of period	48,018	51,056
Cash and cash equivalents, end of period	44,853	71,481
Cash and cash equivalents, end of period — continuing operations	44,754	71,376
Cash and cash equivalents, end of period — discontinued operations	99	105
Supplemental disclosure of cash flow information:
Cash paid for income taxes	317	598
Cash paid for interest	221	2,939
Supplemental disclosure of noncash information:
Transfer of loans receivable, net to loans held for sale, net		21,846
Transfer of nonmarketable equity securities from other noncurrent assets to other current assets		1,940
Continuing Operations
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Change in fair value of common stock warrant liability	(3,400)	8,450
Goodwill impairment	$ 400